As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  4:25pm† NeuBase Therapeutics, Inc.        8-K:5,9     5/13/24   10:198K                                   Toppan Merrill/FA        
  5/3/24  NeuBase Therapeutics, Inc.        8-K:3,9      5/2/24   10:193K                                   Toppan Merrill/FA        
  4/5/24  NeuBase Therapeutics, Inc.        8-K:3,8,9    4/4/24   11:201K                                   Toppan Merrill/FA        
  3/7/24  NeuBase Therapeutics, Inc.        8-K:8,9      3/5/24   11:225K                                   Toppan Merrill/FA        
 2/23/24  NeuBase Therapeutics, Inc.        8-K:8,9     2/22/24   10:194K                                   Toppan Merrill/FA        
 1/26/24  NeuBase Therapeutics, Inc.        8-K:1,9     1/26/24   11:249K                                   Toppan Merrill/FA        
12/28/23  NeuBase Therapeutics, Inc.        8-K:1,9    12/27/23   12:281K                                   Toppan Merrill/FA        
10/18/23  NeuBase Therapeutics, Inc.        8-K:1,9    10/17/23   12:418K                                   Toppan Merrill/FA        
 9/18/23  NeuBase Therapeutics, Inc.        8-K:5,9     9/15/23   11:195K                                   Toppan Merrill/FA        
  8/3/23  NeuBase Therapeutics, Inc.        8-K:2,7,9   7/28/23   11:178K                                   Toppan Merrill Bridge/FA 
 7/31/23  NeuBase Therapeutics, Inc.        8-K:5,9     7/28/23   11:178K                                   Toppan Merrill Bridge/FA 
 6/30/23  NeuBase Therapeutics, Inc.        8-K:1,3,8,9 6/28/23   21:1.6M                                   Toppan Merrill/FA        
 6/14/23  NeuBase Therapeutics, Inc.        8-K:3,5,7,9 6/14/23   12:207K                                   Toppan Merrill Bridge/FA 
 5/22/23  NeuBase Therapeutics, Inc.        8-K:7,9     5/22/23   12:3.4M                                   Toppan Merrill Bridge/FA 
 5/11/23  NeuBase Therapeutics, Inc.        8-K:2,9     5/11/23   11:190K                                   Toppan Merrill Bridge/FA 
 2/14/23  NeuBase Therapeutics, Inc.        8-K:2,9     2/14/23   11:207K                                   Toppan Merrill/FA        
12/29/22  NeuBase Therapeutics, Inc.        8-K:1,9    12/28/22   11:379K                                   Toppan Merrill/FA        
12/21/22  NeuBase Therapeutics, Inc.        8-K:2,9    12/21/22   11:218K                                   Toppan Merrill/FA        
10/14/22  NeuBase Therapeutics, Inc.        8-K:2,5,8,9 10/7/22   11:214K                                   Toppan Merrill/FA        
 9/12/22  NeuBase Therapeutics, Inc.        8-K:5,8,9    9/8/22   11:249K                                   Toppan Merrill/FA        

____________
†	The Filing’s time of SEC acceptance (U.S. Eastern Time).  The SEC’s Filings System is “open” Monday through Friday from 6am to 10pm ET. Because the SEC “closes” at 5:30pm ET, most subsequently-accepted Filings won’t be released to the public until sometime after 6am ET the next day.
¹	Filing/Form Type:  -K
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.